280 related articles for article (PubMed ID: 12024046)
1. Cartilage oligomeric matrix protein-deficient mice have normal skeletal development.
Svensson L; Aszódi A; Heinegård D; Hunziker EB; Reinholt FP; Fässler R; Oldberg A
Mol Cell Biol; 2002 Jun; 22(12):4366-71. PubMed ID: 12024046
[TBL] [Abstract][Full Text] [Related]
2. A mouse model offers novel insights into the myopathy and tendinopathy often associated with pseudoachondroplasia and multiple epiphyseal dysplasia.
Piróg KA; Jaka O; Katakura Y; Meadows RS; Kadler KE; Boot-Handford RP; Briggs MD
Hum Mol Genet; 2010 Jan; 19(1):52-64. PubMed ID: 19808781
[TBL] [Abstract][Full Text] [Related]
3. Diverse mutations in the gene for cartilage oligomeric matrix protein in the pseudoachondroplasia-multiple epiphyseal dysplasia disease spectrum.
Briggs MD; Mortier GR; Cole WG; King LM; Golik SS; Bonaventure J; Nuytinck L; De Paepe A; Leroy JG; Biesecker L; Lipson M; Wilcox WR; Lachman RS; Rimoin DL; Knowlton RG; Cohn DH
Am J Hum Genet; 1998 Feb; 62(2):311-9. PubMed ID: 9463320
[TBL] [Abstract][Full Text] [Related]
4. Characterization of cartilage oligomeric matrix protein (COMP) in human normal and pseudoachondroplasia musculoskeletal tissues.
Hecht JT; Deere M; Putnam E; Cole W; Vertel B; Chen H; Lawler J
Matrix Biol; 1998 Aug; 17(4):269-78. PubMed ID: 9749943
[TBL] [Abstract][Full Text] [Related]
5. Selective intracellular retention of extracellular matrix proteins and chaperones associated with pseudoachondroplasia.
Vranka J; Mokashi A; Keene DR; Tufa S; Corson G; Sussman M; Horton WA; Maddox K; Sakai L; Bächinger HP
Matrix Biol; 2001 Nov; 20(7):439-50. PubMed ID: 11691584
[TBL] [Abstract][Full Text] [Related]
6. Retention of cartilage oligomeric matrix protein (COMP) and cell death in redifferentiated pseudoachondroplasia chondrocytes.
Hecht JT; Montufar-Solis D; Decker G; Lawler J; Daniels K; Duke PJ
Matrix Biol; 1998 Dec; 17(8-9):625-33. PubMed ID: 9923655
[TBL] [Abstract][Full Text] [Related]
7. Reduced cell proliferation and increased apoptosis are significant pathological mechanisms in a murine model of mild pseudoachondroplasia resulting from a mutation in the C-terminal domain of COMP.
Piróg-Garcia KA; Meadows RS; Knowles L; Heinegård D; Thornton DJ; Kadler KE; Boot-Handford RP; Briggs MD
Hum Mol Genet; 2007 Sep; 16(17):2072-88. PubMed ID: 17588960
[TBL] [Abstract][Full Text] [Related]
8. Matrilin-3 is dispensable for mouse skeletal growth and development.
Ko Y; Kobbe B; Nicolae C; Miosge N; Paulsson M; Wagener R; Aszódi A
Mol Cell Biol; 2004 Feb; 24(4):1691-9. PubMed ID: 14749384
[TBL] [Abstract][Full Text] [Related]
9. Identification of nine novel mutations in cartilage oligomeric matrix protein in patients with pseudoachondroplasia and multiple epiphyseal dysplasia.
Deere M; Sanford T; Francomano CA; Daniels K; Hecht JT
Am J Med Genet; 1999 Aug; 85(5):486-90. PubMed ID: 10405447
[TBL] [Abstract][Full Text] [Related]
10. COMP mutations, chondrocyte function and cartilage matrix.
Hecht JT; Hayes E; Haynes R; Cole WG
Matrix Biol; 2005 Jan; 23(8):525-33. PubMed ID: 15694129
[TBL] [Abstract][Full Text] [Related]
11. Mutations in cartilage oligomeric matrix protein causing pseudoachondroplasia and multiple epiphyseal dysplasia affect binding of calcium and collagen I, II, and IX.
Thur J; Rosenberg K; Nitsche DP; Pihlajamaa T; Ala-Kokko L; Heinegård D; Paulsson M; Maurer P
J Biol Chem; 2001 Mar; 276(9):6083-92. PubMed ID: 11084047
[TBL] [Abstract][Full Text] [Related]
12. Abnormal bone quality in cartilage oligomeric matrix protein and matrilin 3 double-deficient mice caused by increased tissue inhibitor of metalloproteinases 3 deposition and delayed aggrecan degradation.
Groma G; Xin W; Grskovic I; Niehoff A; Brachvogel B; Paulsson M; Zaucke F
Arthritis Rheum; 2012 Aug; 64(8):2644-54. PubMed ID: 22378539
[TBL] [Abstract][Full Text] [Related]
13. Identification of twelve mutations in cartilage oligomeric matrix protein (COMP) in patients with pseudoachondroplasia.
Deere M; Sanford T; Ferguson HL; Daniels K; Hecht JT
Am J Med Genet; 1998 Dec; 80(5):510-3. PubMed ID: 9880218
[TBL] [Abstract][Full Text] [Related]
14. A novel form of chondrocyte stress is triggered by a COMP mutation causing pseudoachondroplasia.
Suleman F; Gualeni B; Gregson HJ; Leighton MP; Piróg KA; Edwards S; Holden P; Boot-Handford RP; Briggs MD
Hum Mutat; 2012 Jan; 33(1):218-31. PubMed ID: 22006726
[TBL] [Abstract][Full Text] [Related]
15. Novel and recurrent COMP (cartilage oligomeric matrix protein) mutations in pseudoachondroplasia and multiple epiphyseal dysplasia.
Ikegawa S; Ohashi H; Nishimura G; Kim KC; Sannohe A; Kimizuka M; Fukushima Y; Nagai T; Nakamura Y
Hum Genet; 1998 Dec; 103(6):633-8. PubMed ID: 9921895
[TBL] [Abstract][Full Text] [Related]
16. Ablation of collagen IX and COMP disrupts epiphyseal cartilage architecture.
Blumbach K; Niehoff A; Paulsson M; Zaucke F
Matrix Biol; 2008 May; 27(4):306-18. PubMed ID: 18191556
[TBL] [Abstract][Full Text] [Related]
17. [Progress of molecular genetic research on pseudoachon-droplasia and multiple epiphyseal dysplasia].
Wang JJ; Guo YB
Yi Chuan; 2008 May; 30(5):537-42. PubMed ID: 18487141
[TBL] [Abstract][Full Text] [Related]
18. Calreticulin, PDI, Grp94 and BiP chaperone proteins are associated with retained COMP in pseudoachondroplasia chondrocytes.
Hecht JT; Hayes E; Snuggs M; Decker G; Montufar-Solis D; Doege K; Mwalle F; Poole R; Stevens J; Duke PJ
Matrix Biol; 2001 Jul; 20(4):251-62. PubMed ID: 11470401
[TBL] [Abstract][Full Text] [Related]
19. Molecular cloning and expression patterns of mouse cartilage oligomeric matrix protein gene.
Kipnes JR; Xu L; Han F; Rallapalli R; Jimenez S; Hall DJ; Tuan RS; Li Y
Osteoarthritis Cartilage; 2000 May; 8(3):236-9. PubMed ID: 10806052
[TBL] [Abstract][Full Text] [Related]
20. Cartilage oligomeric matrix protein promotes cell attachment via two independent mechanisms involving CD47 and alphaVbeta3 integrin.
Rock MJ; Holden P; Horton WA; Cohn DH
Mol Cell Biochem; 2010 May; 338(1-2):215-24. PubMed ID: 20033473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
